Clinical Trial Update: FLOX in Combination With Cetuximab in First-line Treatment of Colorectal Cancer [Phase 3]

View source ↗

Summary

Phase 3 trial evaluating the FLOX chemotherapy regimen in combination with cetuximab as first-line treatment for metastatic colorectal cancer; the study status …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Colorectal Cancer

Drugs mentioned

• 5-Fluorouracil (5-FU)
• Cetuximab (cetuximab)
• FLOX regimen
• Leucovorin (folinic acid)
• OXALIPLATIN (Oxaliplatin)

Snippet

Sponsor: The Nordic Colorectal Cancer Biomodulation Group | Conditions: Metastatic Colorectal Cancer | Phase 3 | Status: COMPLETED